Login / Signup

In Vitro Activity of Tebipenem (SPR859) against Penicillin-Binding Proteins of Gram-Negative and Gram-Positive Bacteria.

Evelyne LacasseEric BrouilletteAudrey LaroseThomas R ParrAileen RubioFrançois Malouin
Published in: Antimicrobial agents and chemotherapy (2019)
Tebipenem (SPR859) is the microbiologically active form of SPR994 (tebipenem-pivoxil), an orally available carbapenem with activity against extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae Measurement of the relative binding of SPR859 to the bacterial cell targets revealed that it is a potent inhibitor of multiple penicillin-binding proteins (PBPs) but primarily a Gram-negative PBP 2 inhibitor, similar to other compounds in this class. These data support further clinical development of SPR994.
Keyphrases
  • gram negative
  • multidrug resistant
  • klebsiella pneumoniae
  • drug resistant
  • acinetobacter baumannii
  • single cell
  • escherichia coli
  • big data
  • electronic health record
  • binding protein
  • urinary tract infection